GLP-1 CollectiveLost coverage map
Help us show that losing GLP-1 coverage is a widespread problem
This map shows where people have told us they lost access to their GLP-1 medication. Nobody officially keeps track of this, so we're counting.
Pick a state
Who we are
The GLP-1 Collective is a nonprofit (a 501(c)(3)) that helps people get and keep access to GLP-1 medications. It started in 2025, after our founder's national petition for affordable GLP-1 access got 27,000 signatures and it was clear people needed somewhere to turn.
Everything we do is free. We explain your options with insurance, Medicare, Medicaid and paying on your own, we help you appeal a denial, and we keep the lost coverage count so lawmakers and insurers can see how many people this affects.
Just so you know, we don't sell, prescribe, distribute or provide medication, and we can't give medical advice.
Medicare and Medicaid
Medicare and Medicaid have different rules
A lot of what you see online only applies to one of them, so it's easy to get mixed up. We've explained each one separately so you can start with the one you have.
If you are on Medicare
The Medicare GLP-1 Bridge caps what you pay for covered GLP-1 medications from 1 July 2026 through 31 December 2027. Your Part D plan does not have to opt in for you to use it. It does not count toward your deductible or your annual out-of-pocket limit, and it closes the manufacturer savings cards to you.
If you are on Medicaid
Every state already covers these medications for type 2 diabetes, because federal rules require it. Coverage for weight is the part that varies: some states cover it, a handful have ended or cut back what they had, and the rest cover diabetes only. Our Medicaid map shows where your state stands and how to ask for coverage.
GLP-1 Access
Help for however you pay
Most people come to us with questions about getting or paying for their medication. These pages go into more detail depending on how you pay.
If you have insurance
How your plan decides whether to cover your medication, including prior authorization and step therapy, and how to appeal if the answer is no.
Medicare and Medicaid
The $50 Bridge copay, the federal rule that closes savings cards to anyone on a government plan, and the map of what your state's Medicaid actually covers.
If you are paying cash
What Zepbound, Wegovy and Ozempic cost dose by dose when you pay yourself, and what to expect after the starting price.
Manufacturer programs
The Lilly and Novo Nordisk savings cards: what they take off, the caps, the expiry dates, and who is excluded.
Compounded GLP-1s
What compounding is, what the FDA has restricted since the shortages ended, and the risks to weigh before you go that way.
Prescription assistance
Programs run by other organizations that help reduce what you pay. What they cover, who qualifies, and how to apply.
Appeal letter builder
A free tool that drafts an appeal letter for a denied prescription. It runs in your browser and nothing you type is sent anywhere.
More from the Collective
All of our info and tools are free
What GLP-1s are
How these medications work and what to expect when you start, including side effects, with sources for each.
Tools and calculators
Protein, water, fiber, plate building, progress tracking, side-effect guidance and more.
Policy tracker
Bills, lawsuits and coverage decisions, explained in plain language for patients and families.
Community
Support groups and live sessions with people who get what you're going through. It's free to join.
Teens and adolescents
Which medications are approved for teenagers, for what, and from what age.
Stay current
Email updates
We'll send you news about access and new laws. It's free, and you can unsubscribe anytime.